CLINICAL_TRIALS
trial_result
· 2018-07-30
Clinical Trial Update: Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine [Phase 4]
Summary
A Phase 4 study indicates that onabotulinumtoxinA provides sustained therapeutic benefits for patients with chronic migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Corfu Headache Clinic | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED